Industry News prev

Mar 13 2019

Rocklatan FDA Approved

posted by: J. James Thimons, OD, FAAO

The much anticipated release of Rocklatan has occurred. This agent has two mechanisms of action. RockNet Inhibition and Uveoslceral pathway activation. The IOP lowering profile is significant and it promises to be a great new addition to our armamentarium. Click on the article below to read the full press release from Aerie Pharmaceuticals.